EAU 2023 | Diagnosing and treating castration resistant prostate cancer

Juan Gómez Rivas, MD, PhD, Clínico San Carlos University Hospital, Madrid, Spain, summarizes updated data from key topics in castration-resistant prostate cancer (CRPC), including with diagnoses with PSA and imaging and the importance of genomic testing. Dr Rivas additionally highlights treatment sequencing and personalizing medicine for patients with CRPC. This interview took place at the EAU congress in Milan, Italy.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.